[Neurotrophic factor treatment in amyotrophic lateral sclerosis].
Tsuzaka
K
K
Department of Neurology and Neuroscience, Cleveland Clinic Foundation, Ohio 44195, USA.
Mitsumoto
H
H
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000627:therapeutic use*; D020934:Ciliary Neurotrophic Factor; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D009414:Nerve Growth Factors / Q000627:therapeutic use*; D009419:Nerve Tissue Proteins / Q000627:therapeutic use*
D019208:Brain-Derived Neurotrophic Factor; D020934:Ciliary Neurotrophic Factor; C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D007334:Insulin-Like Growth Factor I